MSLP - MusclePharm Corporation

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 513.19M
Enterprise Value 330.17M
Trailing P/E 34.62
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)0.13
Price/Book (mrq)N/A
Enterprise Value/Revenue 30.29
Enterprise Value/EBITDA 6-3.70

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Sep 30, 2017

Profitability

Profit Margin 0.34%
Operating Margin (ttm)-9.52%

Management Effectiveness

Return on Assets (ttm)-17.85%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)102.62M
Revenue Per Share (ttm)7.66
Quarterly Revenue Growth (yoy)-20.50%
Gross Profit (ttm)44.47M
EBITDA -8.16M
Net Income Avi to Common (ttm)345k
Diluted EPS (ttm)0.03
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)4.88M
Total Cash Per Share (mrq)0.33
Total Debt (mrq)22.16M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.17
Book Value Per Share (mrq)-0.78

Cash Flow Statement

Operating Cash Flow (ttm)-16.92M
Levered Free Cash Flow (ttm)-27.35M

Trading Information

Stock Price History

Beta 3.35
52-Week Change 3-50.00%
S&P500 52-Week Change 314.22%
52 Week High 32.25
52 Week Low 30.37
50-Day Moving Average 30.91
200-Day Moving Average 31.03

Share Statistics

Avg Vol (3 month) 317k
Avg Vol (10 day) 36.86k
Shares Outstanding 514.65M
Float 8.57M
% Held by Insiders 132.37%
% Held by Institutions 19.19%
Shares Short 3N/A
Short Ratio 3N/A
Short % of Float 3N/A
Shares Short (prior month) 3N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/850
Last Split Date 3Nov 26, 2012